U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease

FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
Health and Me on MSN

Bryan Johnson's autoimmune gastritis sheds light on iron deficiency in Americans

Since receiving the diagnosis of Autoimmune Gastritis, Bryan Johnson has begun iron infusions, which deliver a full dose of ...

Agios Pharmaceuticals, Inc.: U.S. FDA Grants Priority Review to Agios' sNDA for Mitapivat in Sickle Cell Disease

FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Newsner on MSN

Biohacker Bryan Johnson reveals he has incurable disease – after spending $2million a year not to age

Despite investing more than $2 million a year into his health, Bryan Johnson says he has been diagnosed with an incurable ...